Choose date and time: ×
In the last hour
The perils of unapproved stents The News International 00:53
Earlier today
In the last 2 hours
In the last 4 hours
Better Buy: Biogen Inc. vs. Gilead Sciences Inc. The Motley Fool 22:45 24-Jan-17
Azelis lands nitroalkanes distribution deal with Angus Chemical in-PharmaTechnologist.com 22:13 24-Jan-17
Johnson & Johnson CEO says some Obamacare provisions should be kept Morning Call, Pennsylvania 21:57 24-Jan-17
ADMA to buy US Biotest plant and fix problems that derailed RI-002 in-PharmaTechnologist.com 21:43 24-Jan-17
Sun declines to comment on New Jersey plant sale speculation in-PharmaTechnologist.com 21:43 24-Jan-17
Marinus Announces Positive Preliminary Data for Ganaxolone Drug Discovery & Development 21:33 24-Jan-17
In the last 6 hours
Johnson & Johnson: No Reason To Step In And Buy Seeking Alpha 20:44 24-Jan-17
Latest Research Offers Hope for Patients With Inflammatory Diseases Drug Discovery & Development 20:32 24-Jan-17
Highlighting Biotech's Versartis' Potential Seeking Alpha 19:55 24-Jan-17
In the last 8 hours
UnitedHealth Looks Beyond Insurance to Help Fuel 4Q Growth Drug Discovery & Development 19:22 24-Jan-17
Customized pharmaceutical sieves for high-containment screening European Pharmaceutical Review 18:50 24-Jan-17
Pancreatic Cancer Field Awaits Sparse Data Seeking Alpha 18:34 24-Jan-17
J&J Needs a Fix for a Pharma Slowdown Bloomberg 18:30 24-Jan-17
Malaria Drug Successfully Treats 26-Year Old Brain Cancer Patient Drug Discovery & Development 18:22 24-Jan-17
Biocon's Q3 profits rise by 65% to Rs 171 cr The Business Standard 17:49 24-Jan-17
Biocon Q3 net up 65% to Rs 171.3 crore The Economic Times 17:49 24-Jan-17
Yesterday
Ron Johnson pushes "right-to-try" legislation Milwaukee Journal Sentinel 17:16 24-Jan-17
Johnson & Johnson: Buy The Dip? Seeking Alpha 16:44 24-Jan-17
Common Heart Drug Repurposed to Treat Rare Cancer in Europe Drug Discovery & Development 16:32 24-Jan-17
3 Stocks Dominating the Future of Healthcare The Motley Fool 16:12 24-Jan-17
Allergan, Teva unit face FTC scrutiny of deals Taipei Times 16:02 24-Jan-17
Takeda to acquire Ariad Pharmaceuticals Trade Arabia 15:29 24-Jan-17
The FDA's Newly Proposed GMO Rules Are Nonsense Gizmodo US (Weblog) 15:28 24-Jan-17

About our Pharma news...

NewsNow aims to be the world's most accurate and comprehensive pharmaceutical news aggregator, bringing you the latest headlines from the best pharma sites and other key national and regional news sources. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication. N.B. Relevance is automatically assessed so some headlines not qualifying as pharma news might appear - please feel free to contact us regarding any persistent issues. [Read more]

No account? Sign up!

  • Bookmark your favourite topics and create your very own NewsNow page.
  • Save publication preferences and your reading history for quick reference.
  • Take this with you whenever and wherever you sign in!

Publication filters

Headline Density

  • This site uses cookies. To see how, read our Privacy and Cookie Notice. If you disagree with our use of cookies, please navigate away.
Sorry, no headlines or news topics were found. Please try different keywords.